Rachel Musomba, Barbara Castelnuovo, Claire V. Murphy, C Komujuni, Patience Nyakato, Ponsiano Ocama, Mohammed Lamorde, Philippa Easterbrook, Rosalind Parkes-Ratanshi
David FitzSimons, Greet Hendrickx, Johannes Hallauer, Heidi Larson, Daniel Lavanchy, Ina Lodewyckx, Daniel Shouval, John Ward, Pierre Van Damme
Hepatitis B is preventable and hepatitis C is treatable even if still at a high
cost; most people who are infected with hepatitis B or C virus have not been
screened yet and are unaware of their infections; and most countries, especially
developing countries, do not have a national plan to prevent and control viral
hepatitis. The advent of effective new treatments for hepatitis C has been an
agent... hiện toàn bộ
The Hepatitis C virus (HCV) is very common among people who inject drugs (PWID),
yet PWID in India have suboptimal access to HCV testing and treatment. This
study sought to identify HCV risk factors among male PWID who utilized a free
needle and syringe exchange program and to examine the predisposing, enabling,
and need factors associated with utilization of HCV testing services by those
PWID rep... hiện toàn bộ
Jacqueline A. Richmond, Jeanne Ellard, Jack Wallace, Rachel Thorpe, Peter Higgs, Margaret Hellard, Alexander Thompson
Universal access to the hepatitis C direct acting antiviral (DAAs) regimens
presents a unique opportunity to eliminate hepatitis C in Australia. Large
numbers of Australians have already been cured using these treatments, however,
the numbers presenting for treatment have begun to plateau. This study explored
how people experienced and understood being cured of hepatitis C, with the aim
of informi... hiện toàn bộ